Series C - NewBridge Pharmaceuticals
Investment Firm
Overview
Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.
Announced Date
May 29, 2013
Funding Type
Series C
Highlights
Location
Asia
Social
Investor Lead
Participant Investors
3
Round Details and Background
NewBridge Pharmaceuticals raised $48000000 on 2013-05-29 in Series C
Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 29, 2013 |  Series C - NewBridge Pharmaceuticals | 3 | - | 48.0M |
| Sep 20, 2010 | Series B - NewBridge Pharmaceuticals | 2 | - | 12.0M |
Recent Activity
There is no recent news or activity for this profile.